Ganna Bilousova, PhD (she/her/hers)

University of Colorado Anschutz Medical Campus, USA

My laboratory has a long-standing interest in induced pluripotent stem cells (iPSCs) and their differentiation capacity into a variety of cell types. I am particularly interested in developing experimental iPSC-based therapies for skin blistering diseases, such as Epidermolysis Bullosa. In addition, my group is working on identifying genetic causes of the Ehlers-Danlos Syndrome, a group of skin and connective tissue disorders characterized by hyperextensible skin, joint hypermobility, cutaneous fragility, delayed wound healing, and chronic pain. My group also studies the pathways that trigger a senescence-associated secretory phenotype in disease tissues.

Presentation(s):

• EMERGING NEW THERAPIES

  Thursday, July 11, 2024
  8:15 AM – 9:45 AM CEST

• A PERSONALIZED iPSC-BASED THERAPY FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA DELIVERED VIA CELL SUSPENSION: PRE-CLINICAL DEVELOPMENT

  Thursday, July 11, 2024
  8:20 AM – 8:40 AM CEST

• UPDATES ON CLINICAL TRIALS

  Saturday, July 13, 2024
  8:15 AM – 9:45 AM CEST